Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    ONO-4641
Show Display Options
Rank Status Study
1 Terminated
Has Results
Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis
Intervention: Drug: ONO-4641
2 Completed A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ONO-4641;   Drug: ONO-4641 placebo

Indicates status has not been verified in more than two years